Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Multiple DNA cleavage pathways identified for aza-enediyne compound

Sep. 6, 2001

CytRx reports positive preclinical results for CRL-5861 in cancer

Sep. 6, 2001

FDA grants orphan drug status for new Genasense indications

Sep. 5, 2001

MMP-1-sparing matrix metalloproteinase inhibitors possessing antiangiogenic/antitumor properties

Sep. 5, 2001

ACS news: preparation of ABT-839 for toxicology and clinical studies

Sep. 5, 2001

MediGene signs agreement with Memorial Sloan-Kettering for HSV in cancer treatment

Sep. 5, 2001

OraPharma commences phase I trial of OC-1012 for mucositis prevention

Sep. 5, 2001

AstraZeneca reassesses ZD-0473 phase III clinical program in ovarian cancer

Sep. 4, 2001

Eisai describes new neovascularization inhibitors in patent literature

Sep. 3, 2001

Antisoma takes on development of promising vascular targeting agent from the CRC

Sep. 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...